As the number of malaria cases in India continues to soar, the drug treatment medication can be costly.
A new report from the Medical Council of India reveals that there are many drugs that are available to treat malaria that cost around $10,000 per month.
However, the report also found that some drugs are cheap but some are expensive.
It said that it had reviewed data of over 400 drugs and found that of the cheapest ones, most of them were prescribed by health care workers and their families.
The drugs are cheaper than other drugs like the generic drugs.
The cheapest drugs are usually generic versions of existing medications and the most expensive ones are cheaper versions.
The report also showed that the drugs are generally prescribed by doctors who are not licensed to prescribe drugs and are therefore not certified as doctors.
According to the report, a few drugs have a generic version and are also available at the cheapest prices, while the cheaper ones are usually cheaper versions of the same drug.
The other drugs are prescribed by healthcare workers and families who can be expensive and they can also be difficult to find in India.
The report said that the majority of the drugs in the list are generic versions and there are two drugs which are brand new versions of generic drugs, while there are others which are generic.
The new versions are cheaper and more effective than the old versions, but there are also other drugs in which the generic version has been replaced by the brand new version.
The drugs are typically prescribed by professionals who are certified by the Medical Board of India (MBI) and the quality of their medication is high.
The medical board said that these drugs are being prescribed by nurses, doctors and others who are licensed to administer drugs.
However, the board said it is still too early to determine whether these drugs will become the first in the country to be approved for use in the national market.
The National Institute of Health (NHI) is set to issue the government with a report on malaria treatment drugs next week.
The NHI report will be made public next month.